Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 2/2015

Inhalt (19 Artikel)

Review – Cancer Research

The biological and clinical importance of epithelial–mesenchymal transition in circulating tumor cells

Huiying Liu, Xiaofeng Zhang, Jun Li, Bin Sun, Haihua Qian, Zhengfeng Yin

Original Article – Cancer Research

FTS is responsible for radiation-induced nuclear phosphorylation of EGFR and repair of DNA damage in cervical cancer cells

Sridhar Muthusami, D. S. Prabakaran, Jae-Ran Yu, Woo-Yoon Park

Original Article – Cancer Research

Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer

Z. Yang, D. M. Li, Q. Xie, D. Q. Dai

Original Article – Cancer Research

ARMS for EGFR mutation analysis of cytologic and corresponding lung adenocarcinoma histologic specimens

Jinguo Liu, Ruiying Zhao, Jie Zhang, Jian Zhang

Original Article – Cancer Research

SALL4 as a new biomarker for early colorectal cancers

Sima Ardalan Khales, Mohammad Reza Abbaszadegan, Abbas Abdollahi, Reza Raeisossadati, Mohsen Fallah Tousi, Mohammad Mahdi Forghanifard

Original Article – Cancer Research

The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest

Entidhar Al Sawah, Douglas C. Marchion, Yin Xiong, Ingrid J. Ramirez, Forough Abbasi, Bernadette M. Boac, Stephen H. Bush, Nadim Bou Zgheib, E. Clair McClung, Beman R. Khulpateea, Amy Berry, Ardeshir Hakam, Robert M. Wenham, Johnathan M. Lancaster, Patricia L. Judson

Original Article – Cancer Research

Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling

C. Henry, A. Quadir, N. J. Hawkins, E. Jary, E. Llamosas, D. Kumar, B. Daniels, R. L. Ward, C. E. Ford

Original Article – Cancer Research

Dieckol, isolated from the edible brown algae Ecklonia cava, induces apoptosis of ovarian cancer cells and inhibits tumor xenograft growth

Ji-Hye Ahn, Yeong-In Yang, Kyung-Tae Lee, Jung-Hye Choi

Original Article – Cancer Research

Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway

Rong-kun Li, Wen-yi Zhao, Fang Fang, Chun Zhuang, Xiao-xin Zhang, Xiao-mei Yang, Shu-heng Jiang, Fan-zhi Kong, Lin Tu, Wen-Ming Zhang, Sheng-li Yang, Hui Cao, Zhi-gang Zhang

Original Article – Cancer Research

Inhibition of 32Dp210 cells harboring T315I mutation by a novel derivative of emodin correlates with down-regulation of BCR-ABL and its downstream signaling pathways

Jing Li, Yingyu Chen, Buyuan Chen, Cai Chen, Binglin Qiu, Zhihong Zheng, Jing Zheng, Tingbo Liu, Wenfeng Wang, Jianda Hu

Original Article – Clinical Oncology

Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer

Tetsuro Ikeya, Masatsune Shibutani, Kiyoshi Maeda, Kenji Sugano, Hisashi Nagahara, Hiroshi Ohtani, Kosei Hirakawa

Original Article – Clinical Oncology

DJ-1: a promising marker in metastatic uveal melanoma

Li-Li Chen, Jian-Jun Tian, Liang Su, Yan Jing, Shi-Cai Zhang, Hong-Xing Zhang, Xiao-Qing Wang, Cheng-Bao Zhu

Open Access Original Article – Clinical Oncology

Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy

Yusuke Okuma, Makoto Saito, Yukio Hosomi, Toshikazu Sakuyama, Tatsuru Okamura

Original Article – Clinical Oncology

Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center

Yen-Lin Chen, Cheng-Yi Wang, Chin-Chia Wu, Moon-Sing Lee, Shih-Kai Hung, Wei-Chou Chen, Chih-Yao Hsu, Chia-Wen Hsu, Chih-Yuan Huang, Yu-Chieh Su, Ching-Chih Lee

Original Article – Clinical Oncology

Clinicopathologic characteristics and prognostic factors of sarcomatoid renal cell carcinoma

Yi Yan, Longfei Liu, Jingyu Zhou, Liling Li, Yuan Li, Minfeng Chen, Long Wang, Wei He, Xiao Guan, Xiongbing Zu, Lin Qi

Original Article – Clinical Oncology

Comparison of restaging accuracy of repeat FDG-PET/CT with pelvic MRI after preoperative chemoradiation in patients with rectal cancer

Jung Wook Huh, Seong Young Kwon, Jae Hyuk Lee, Hyeong Rok Kim

Original Article – Clinical Oncology

Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study

Esra Kaytan Saglam, Serap Yucel, Emre Balik, Sezer Saglam, Oktar Asoglu, Sumer Yamaner, Dursun Bugra, Ethem N. Oral, Ahmet Kizir, Yersu Kapran, Burak Sakar, Ali Akyuz, Mine Gulluoglu

Original Article – Clinical Oncology

Protein deep sequencing applied to biobank samples from patients with pancreatic cancer

Daniel Ansari, Roland Andersson, Monika P. Bauden, Bodil Andersson, Joanne B. Connolly, Charlotte Welinder, Agata Sasor, György Marko-Varga

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.